Please assess the completion status of the following clinical trial:

Trial Title: Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Informed Consent~* Between 18 and 75 years of age inclusive~* VAP - 48 hours after onset of mechanical ventilation~* BMI 18 - 35 inclusive~* Albumin \< 3.3 g/dL or clinical evidence of edema~* Negative Pregnancy test~* Expected survival of at least 7 days~Exclusion Criteria:~* Renal impairment (CrCl \< 80 mL/min)~* Known drug allergy (including penicillin, cephalosporin, carbapenems, or other beta-lactams)~* History of seizures~* Sustained shock, unresponsive to sympathomimetics~* Conditions that may have jeopardized adherence to the protocol (NYHA Class 4 cardiac disease, \>15% total body burn or significant third degree burn)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Ceftobiprole (Type: EXPERIMENTAL): Ceftobiprole, 1 G q8h as 4 hour infusions for 2 days

Based on this trial design, predict the completion outcome and termination type (if applicable).